- Home
- ARWR vs FROG Comparison
ARWR vs FROG Comparison
Compare ARWR & FROG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | FROG |
|---|---|---|
| Founded | 2003 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 7.9B |
| IPO Year | 1993 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ARWR | FROG |
|---|---|---|
| Price | $67.81 | $53.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 18 |
| Target Price | ★ $73.70 | $66.72 |
| AVG Volume (30 Days) | ★ 2.6M | 1.7M |
| Earning Date | 02-05-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $829,448,000.00 | $502,612,000.00 |
| Revenue This Year | N/A | $24.88 |
| Revenue Next Year | N/A | $16.59 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23258.15 | 22.69 |
| 52 Week Low | $9.57 | $27.00 |
| 52 Week High | $76.76 | $70.43 |
Technical Indicators
Market Signals| Indicator | ARWR | FROG |
|---|---|---|
| Relative Strength Index (RSI) | 57.08 | 34.84 |
| Support Level | $61.65 | $54.27 |
| Resistance Level | $68.24 | $58.78 |
| Average True Range (ATR) | 3.79 | 2.98 |
| MACD | -0.69 | -0.84 |
| Stochastic Oscillator | 45.29 | 6.55 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About FROG JFrog Ltd.
JFrog Ltd provides an end-to-end, hybrid, universal DevOps Platform that powers and controls the software supply chain, enabling organizations to continuously and securely deliver software updates across any system. Its product portfolio includes JFrog Artifactory; JFrog Pipelines; JFrog Xray; JFrog Distribution; JFrog Artifactory Edge; JFrog Mission Control and JFrog Insight. Geographically, it derives a majority of revenue from Israel and also has its presence in United States, India and other regions.